Researchers design prototype system-on-chip that could make fully implanted cochlear implant

Researchers from Massachusetts Eye and Ear, Harvard Medical School, and Massachusetts Institute of Technology (MIT) have designed a prototype system-on-chip (SoC) that could make possible a fully implanted cochlear implant. They will present their findings on Feb. 11at the IEEE International Solid State Circuits Conference in San Francisco.

A cochlear implant is a device that electronically stimulates the auditory nerve to restore hearing in people with profound hearing loss. Conventional cochlear implants are made up of an external unit with a microphone and sound processer to pick up and encode sound, and an internal unit that is seated in the skull and connected to an electrode array inserted into the cochlea. The external unit raises concerns in some individuals with social stigma and has limited use in the shower or during water sports.

"In addition to the cosmetic aspect of an invisible cochlear implant, a potential major functional benefit is that it can facilitate sound localization. Our system relies on a sound sensor located in the middle ear so that the user can benefit from directional cues provided by the auricle and ear canal. Conventional cochlear implants detect sound by a microphone located outside of the ear so that important directional cues are lost," said Konstantina Stankovic, M.D., Ph.D., Mass. Eye and Ear otologist who co-led the study with Anantha Chandrakasan, Ph.D., MIT head of Electrical Engineering and Computer Science. "Our long-term goal is to develop a fully implantable cochlear implant. To facilitate that development, we have developed the SoC and tested it in ears of human cadavers."

In addition, the SoC was designed to require lower power sound processing and auditory nerve stimulation to enable operation from an implantable battery that is wirelessly recharged once daily.

Source: Massachusetts Eye and Ear Infirmary

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide linked to increased risk of severe eye condition NAION in new study